Internal Server Error

List of Lilly's Acquisitions

lockFilter this list
Lilly has made a total of 40 acquisitions. It has completed these across 28 sectors, including Oncology, Neurology, and Immunotherapy, spanning 6 countries such as the United States, United Kingdom, and Canada. Peak years included 11 acquisitions in 2026, 6 in 2023, and 3 in 2025. Between 2020 and 2025, the company averaged 2.8 acquisitions per year, and it has completed 11 acquisitions in the current calendar year. In August 2026, it acquired Meridabio, a Cambridge-based developer of targeted therapies for autoimmune and allergic disorders founded in 2019.

Here's the year on year acquisition history of Lilly:

Year on year acquisition history of Lilly2026202520242023202220212020201920182017Acquisitions Round Date (Yearly)03691215
  • Number of Total Acquisitions
Year
# Acquisitions
2026
11
2025
3
2024
2
2023
6
2022
2
2021
1
2020
3
2019
1
2018
2
2017
1
2016
1
2014
1
2011
1
2010
2
2008
2
2007
1

Recent acquisitions by Lilly

Lilly's most recent acquisition - Meridabio is a Developer of targeted therapies for autoimmune and allergic disorders, founded in 2019 and located in Cambridge. Lilly acquired it in August 2026 for a price of $*****.

Here is the list of all acquisitions by Lilly sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Aug 31, 2026
avwx
cajv
71
364
Jul 16, 2026
aqfb
dbmm
96
259
Jun 16, 2026
y{rb
bq{e
55
374
May 26, 2026
irxl
vuwx
54
605
May 20, 2026
iwah
lplb
46
755

View the full list of acquisitions

Sign Up for Free

News related to Lilly's acquisitions

lockFilter this list

Media has covered Lilly for a total of 441 events in the last 1 year, 79 of them have been about acquisition activity.

View More Lilly Recent News

FAQs about Acquisitions by Lilly

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford